GBIO

Generation Bio Co. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website generationbio.com
Employees(FY) 150
ISIN US37148K1007

Performance

0.0%

-14.39%

-58.39%

-55.93%

-27.88%

YTD

-30.0%

Profile

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Advanced Technical Analysis

Technical Analysis of GBIO 2024-12-20

The Moving Average Score of 23 indicates a bearish sentiment, while the Oscillators Score of 56 suggests a neutral outlook. Overall, the Technical Score of 40 reinforces a neutral stance, indicating that the stock is currently experiencing mixed signals with a slight bearish bias.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of GBIO

Stock Rank

Recent News & Updates

2024-11-06 04:40
Generation Bio Co. (GBIO) Reports Q3 Loss, Tops Revenue Estimates(Yahoo Finance)
2024-11-06 03:05
Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results(Yahoo Finance)
2024-10-21 18:59
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress(Globenewswire)
2024-09-12 04:05
Generation Bio to Present at the 2024 Cantor Global Healthcare Conference(Globenewswire)
2024-08-07 11:54
GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q2 2024(Investorplace)
2024-08-07 07:35
Generation Bio Co. (GBIO) Reports Q2 Loss, Tops Revenue Estimates(Yahoo Finance)
2024-08-07 04:05
Generation Bio Reports Second Quarter 2024 Financial Results(Yahoo Finance)
2024-08-05 18:59
Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference(Globenewswire)
2024-06-13 18:59
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit(Globenewswire)
2024-06-03 04:30
Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?(Insidermonkey)
2024-06-03 04:17
9 Best Gene Therapy Stocks to Buy Now(Insidermonkey)
2024-05-25 11:10
20 Biggest Publicly Traded Biotech Companies(Insidermonkey)
2024-05-13 09:54
GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q1 2024(Investorplace)
2024-05-13 05:15
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates(Zacks)
2024-05-13 04:05
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results(Globenewswire)
2024-05-08 18:59
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting(Globenewswire)
2024-05-03 22:49
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript(Insidermonkey)
2024-04-22 05:31
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting(Globenewswire)
2024-04-01 18:59
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference(Globenewswire)
2024-03-07 15:32
Generation Bio Co Reports Full Year and Q4 2023 Financial Outcomes(Yahoo Finance)
2024-03-06 09:52
GBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q4 2023(Investorplace)
2024-03-06 04:40
Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates(Yahoo Finance)
2024-03-06 03:20
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results(Globenewswire)
2024-02-26 17:59
Generation Bio to Present at the 2024 TD Cowen Health Care Conference(Globenewswire)
2024-01-03 03:05
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference(Globenewswire)
2023-12-05 14:05
Director Rowland Charles A Jr Acquires 342,960 Shares of Generation Bio Co (GBIO)(Yahoo Finance)
2023-11-28 19:41
Generation Bio eliminates 40% of staff, including 2 C-suite execs, in pivot to ex-liver targets(Fiercebiotech)
2023-11-28 17:59
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms(Globenewswire)
2023-11-09 03:15
Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results(Globenewswire)
2023-10-25 18:59
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform(Globenewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.